See also this year's filing and all EDGAR filings for this company.
PDF Report 0001571498_2022_Epizyme_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 37427000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001571498, Epizyme Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 206,043,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 42,849,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,545,000 |
| 3 | remainder_Assets | 38,563,000 |
| 4 | LiabilitiesCurrent | 45,196,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 10,498,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 133,955,000 |
| 9 | ResearchAndDevelopmentExpense | 130,966,000 |
| 10 | remainder_Expenses | 22,000 |
| 11 | remainder_Revenues | 37,427,000 |
| 12 | remainder_NetIncome | -13,108,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 289,000,000 |
| 1 | Liabilities | 45,196,000 |
| 2 | Expenses | 275,441,000 |
| 3 | Revenues | 37,427,000 |
| 4 | StockholdersEquity | 243,804,000 |
| 5 | NetIncome | -251,122,000 |
| 6 | ComprehensiveNetIncome | -251,122,000 |
| 7 | BaseVar | 330,086,000 |
| 8 | EconomicCapitalRatio | 1.01 |
Edgar->Model Mapping
Feature Distribution
Change over Time
